CRPS/RSD Medication Management on Lien: Attorney Guide to High-Value Cases

Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | March 26, 2026 | 7 min read

Complex Regional Pain Syndrome (CRPS/RSD) cases involve multi-drug medication regimens, extended treatment timelines, and high settlement values. This attorney guide covers the specific medications prescribed for CRPS on pharmacy lien, how the pharmacy record documents injury severity, and why CRPS cases consistently command top-tier settlements.

Complex Regional Pain Syndrome (CRPS), previously called Reflex Sympathetic Dystrophy (RSD), produces the most complex medication regimens in personal injury pharmacy — and the pharmacy record it creates is among the most powerful evidence of severe, permanent injury available to PI attorneys. CRPS cases involve five to eight concurrent medications across multiple drug classes, treatment durations measured in years rather than months, and settlement values that routinely reach six and seven figures because the pharmacy record alone documents catastrophic injury.

• CRPS medication regimens typically include gabapentinoids, SNRIs, topical agents, muscle relaxants, and often opioids — five or more concurrent drug classes documenting a multi-system pain condition
• Treatment duration for CRPS averages 2-5 years, with many patients requiring lifelong medication management — the pharmacy lien accrues accordingly
• LienScripts covers every medication in the CRPS regimen on pharmacy lien, and each case receives a MERIT (Medication Evaluation & Rationale for Injury Treatment) report that documents the full multi-drug treatment course
• CRPS is recognized by the International Association for the Study of Pain (IASP) as one of the most painful conditions in medicine — the medication record objectifies this
• According to James Wong, PharmD, founder of LienScripts, "CRPS pharmacy records are the most complex cases we manage, and they produce the most compelling MERIT reports for demand packages"

Why CRPS Cases Are High-Value

CRPS develops after an initial injury — often a fracture, crush injury, or surgery — when the sympathetic nervous system malfunctions and produces pain signals dramatically out of proportion to the original trauma. The Budapest Criteria (Harden et al., Pain Medicine, 2010) require multiple symptoms across sensory, vasomotor, sudomotor, and motor categories for diagnosis.

What makes CRPS cases exceptionally high-value:

1. Disproportionate pain: The pain is objectively more severe than the original injury would predict
2. Spreading symptoms: CRPS can spread from the injured limb to other body regions
3. Treatment resistance: CRPS responds poorly to standard pain management, requiring escalating interventions
4. Functional impairment: Severe CRPS can be career-ending and life-altering
5. Duration: CRPS is frequently permanent, with medications needed indefinitely

The pharmacy record documents all five of these elements through medication type, dose escalation, treatment duration, and the number of concurrent drug classes.

[!KEY] The number of concurrent medications in a CRPS case is itself evidence of injury severity. A patient on six or seven concurrent medications — each targeting a different CRPS mechanism — has a pharmacy record that no adjuster can dismiss as routine or minor injury management.

The CRPS Medication Stack on Lien

Gabapentinoids (Foundation)

Gabapentin and pregabalin are foundational in CRPS treatment, addressing the central sensitization that characterizes the condition.

• Gabapentin — titrated to 1800-3600mg/day (higher than typical nerve pain doses)
• Pregabalin — dosed 300-600mg/day

CRPS-specific significance: The high doses required for CRPS — often at or near the FDA maximum — document that the neuropathic pain component is severe and treatment-resistant. As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains, "A CRPS patient on gabapentin 3600mg/day is at the maximum dose, which tells every reviewer that the nerve pain is as severe as it gets."

SNRIs (Pain + Mood)

Duloxetine or venlafaxine addresses both the chronic pain and the depression/anxiety that invariably accompanies CRPS.

• Duloxetine 60-120mg daily — FDA-approved for chronic musculoskeletal pain and major depression
• Venlafaxine 150-225mg daily — norepinephrine reuptake at higher doses enhances descending pain inhibition

Topical Agents (Localized Treatment)

CRPS pain is often too severe for oral medications alone. Topical agents provide additional relief at the affected site:

• Compound topical creams — combinations of ketamine, gabapentin, baclofen, clonidine, and diclofenac compounded for direct application
• Lidocaine patches — local anesthetic at the pain site
• Capsaicin (Qutenza) 8% patch — applied by a provider; depletes substance P from peripheral nerve endings (Derry et al., Cochrane Database Syst Rev, 2017)

Compound topical creams are particularly significant for case value because they are custom-formulated and typically more expensive than commercial products.

Muscle Relaxants and Antispasmodics

CRPS frequently involves dystonia (involuntary muscle contractions) and spasm:

• Baclofen 30-80mg daily — treats spasticity; higher doses may require intrathecal pump
• Tizanidine 8-24mg daily — alpha-2 agonist for CRPS-related muscle rigidity

Opioids (When Other Agents Fail)

Despite the shift toward non-opioid treatment, many CRPS patients require opioids because the pain is genuinely that severe:

• Extended-release opioids — oxycodone ER, morphine ER for baseline pain control
• Immediate-release opioids — for breakthrough pain episodes

[!TIP] When opioids appear in a CRPS medication record alongside five other drug classes, the opioid prescription is positioned as a last-resort addition to an already-aggressive non-opioid regimen. This context makes the opioid prescription virtually unassailable — the prescriber has clearly tried everything else first and the patient still requires opioid-level analgesia.

Bisphosphonates (Bone Protection)

Emerging evidence supports bisphosphonates (typically alendronate or pamidronate) for CRPS, particularly when bone demineralization is present on imaging (Varenna et al., Rheumatology, 2013).

Sleep and Psychiatric Medications

CRPS patients frequently require concurrent psychiatric medication management:

• Trazodone or mirtazapine for pain-related insomnia
• Prazosin if PTSD from the inciting event causes nightmares
• SSRIs for depression secondary to chronic pain and disability

Documenting CRPS Severity Through Pharmacy Records

The Multi-Class Count

Count the number of distinct drug classes in the CRPS patient's medication profile. Each class documents a separate pain mechanism:

A patient on seven or eight drug classes has documented seven or eight separate pathological mechanisms — a pharmacy-verified picture of catastrophic multi-system injury.

Treatment Duration as Permanence Evidence

CRPS pharmacy records that extend beyond 12 months begin to document permanence. Beyond 24 months, the treatment record supports a life-care plan projection for ongoing medication costs.

LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation for demand packages that details the full CRPS medication regimen, treatment timeline, and clinical rationale.

[!KEY] CRPS cases generate the longest and most complex pharmacy lien records in PI litigation. A two-year treatment history with seven concurrent medications creates a documented record of suffering that is more persuasive than any witness testimony — because it is objective, continuous, and clinically verified at every fill.

Life Care Plan Integration

For permanent CRPS cases, the pharmacy record is essential for the life care plan economist's projections:

• Current monthly medication cost — documented by the pharmacy lien
• Projected duration — based on treatment trajectory (stabilized vs. escalating)
• Expected medication changes — new agents entering the market (e.g., Journavx for CRPS if Nav1.8 trials succeed)
• Annual cost escalation — brand-name drug price increases

These projections transform the pharmacy lien into future damages, often adding significant value to the settlement demand.

If your client has been diagnosed with CRPS following a personal injury, LienScripts covers the entire multi-drug regimen on pharmacy lien — ensuring comprehensive treatment access and documentation from diagnosis through settlement.

Related Resources

• CRPS and RSD Medication Protocols in Personal Injury Cases
• Gabapentin vs. Pregabalin for Personal Injury Cases
• Compound Cream for Personal Injury Pain
• High-Value PI Medication Strategy
• Life Care Plan Pharmacy Costs for PI Attorneys